Pfizer to deliver 10% more doses to U.S. by end of May- CEO
- S&P 500, Dow end at record highs as weak jobs data eases rate worries
- U.S. Added Only 266,000 Jobs in April, Well Below Estimates
- Roku (ROKU) Surges After Crushing Profit Estimates to Prompt an Upgrade to 'Buy' at Loop Capital
- Dollar broadly weaker after U.S. jobs data disappoint
- Square (SQ) Tops Q1 EPS by 25c
FILE PHOTO: A healthcare worker prepares a Pfizer coronavirus disease (COVID-19) vaccination in Los Angeles, California, U.S., January 7, 2021. REUTERS/Lucy Nicholson/File Photo
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
(Reuters) -Pfizer Inc can deliver 10% more doses of its COVID-19 vaccine to the United States by the end of May and meet its target of supplying 300 million doses two weeks earlier than expected, Chief Executive Officer Albert Bourla said in a tweet on Tuesday.
Pfizer had promised to provide the U.S. government with 100 million doses by the end of March and another 100 million by the end of May, with the rest being delivered by the end of July.
Separately, the company said it had conducted an assessment of the vaccines' safety data and had found no evidence of blood clots.
"This safety database analysis includes a review of all adverse events received for the vaccine through March 27," the company said.
Pfizer's statement comes as U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot.
(Reporting by Dania Nadeem in Bengaluru; Editing by Anil D'Silva)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Australia's Star eyes Crown in $7 billion play, vies with private equity
- Valero charters tanker for Gulf Coast storage amid pipeline outage - sources
- Olympics-Amid opposition, Japan PM says has "never put Olympics first"
Create E-mail Alert Related CategoriesGeneral News, Reuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!